Cover Image

Piperlongumine inhibits migration and proliferation of castration-resistant prostate cancer cells via triggering persistent DNA damage

Abstract Background Metastatic castration-resistant prostate cancer (CRPC) is the leading cause of death among men diagnosed with prostate cancer. Piperlongumine (PL) is a novel potential anticancer agent that has been demonstrated to exhibit anticancer efficacy against prostate cancer cells. Howeve...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ding-fang Zhang (Author), Zhi-chun Yang (Author), Jian-qiang Chen (Author), Xiang-xiang Jin (Author), Yin-da Qiu (Author), Xiao-jing Chen (Author), Hong-yi Shi (Author), Zhi-guo Liu (Author), Min-shan Wang (Author), Guang Liang (Author), Xiao-hui Zheng (Author)
Format:	Book
Published:	BMC, 2021-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CCNB1 is a novel prognostic biomarker and promotes proliferation, migration and invasion in Wilms tumor
by: Bin Xiang, et al.
Published: (2023)

Identification of Piperlongumine as Potent Inhibitor of Necroptosis
by: He X, et al.
Published: (2023)

A Novel DNA Aptamer Probe Recognizing Castration Resistant Prostate Cancer in vitro and in vivo Based on Cell-SELEX
by: Zhong J, et al.
Published: (2024)

Adapalene Inhibits Prostate Cancer Cell Proliferation In Vitro and In Vivo by Inducing DNA Damage, S-phase Cell Cycle Arrest, and Apoptosis
by: Hai-bin Nong, et al.
Published: (2022)

Response and Resistance in Castration-Resistant Prostate Cancer
Published: (2020)

Piperlongumine Alleviates Mouse Colitis and Colitis-Associated Colorectal Cancer
by: Jia-Rong Huang, et al.
Published: (2020)

Targeting castration-resistant prostate cancer with a novel RORγ antagonist elaiophylin
by: Jianwei Zheng, et al.
Published: (2020)

Enzalutamide for the treatment of metastatic castration-resistant prostate cancer
by: Rodriguez-Vida A, et al.
Published: (2015)

Evaluation of Silk Fibroin-RGD-Stem Cell Factor Scaffold Effect on Adhesion, Migration, and Proliferation of Stem Cells of Apical Papilla
by: Jie Wei, et al.
Published: (2021)

Evaluation of the Efficacy of PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis
by: Kan Wu, et al.
Published: (2021)

Comparing efficacy of first-line treatment of metastatic castration resistant prostate cancer: a network meta-analysis of randomized controlled trials
by: Yang Liu, et al.
Published: (2023)

Lobaplatin Inhibits Prostate Cancer Proliferation and Migration Through Regulation of BCL2 and BAX
by: Hongwen Cao, et al.
Published: (2019)

The promising potential of piperlongumine as an emerging therapeutics for cancer
by: Dey Parama, et al.
Published: (2021)

Apalutamide: Emerging Therapy for Non-Metastatic Castration-Resistant Prostate Cancer
by: Nora A. Alkhudair
Published: (2019)

Taxane resistance in castration-resistant prostate cancer: mechanisms and therapeutic strategies
by: Brandon Bumbaca, et al.
Published: (2018)

Advanced Therapeutic Options for Treatment of Metastatic Castration Resistant Prostatic Adenocarcinoma
by: Faiza Naseer, et al.
Published: (2021)

PROTACs targeting androgen receptor signaling: Potential therapeutic agents for castration-resistant prostate cancer
by: Yulu Zhang, et al.
Published: (2024)

Dihydroisotanshinone I combined with radiation inhibits the migration ability of prostate cancer cells through DNA damage and CCL2 pathway
by: I-Yun Lee, et al.
Published: (2018)

Telomere-related DNA damage response pathways in cancer therapy: prospective targets
by: Liting Gu, et al.
Published: (2024)

Ilicicolin A Exerts Antitumor Effect in Castration-Resistant Prostate Cancer Via Suppressing EZH2 Signaling Pathway
by: Lang Guo, et al.
Published: (2021)

Integrated high-throughput analysis identifies super enhancers in metastatic castration-resistant prostate cancer
by: Jie Zeng, et al.
Published: (2023)

Piperlongumine Is an NLRP3 Inhibitor With Anti-inflammatory Activity
by: Jie Shi, et al.
Published: (2022)

Association of Monoamine Oxidase A with Tumor Burden and Castration Resistance in Prostate Cancer
by: Meenakshi Meenu, MBBS, MD, DM, et al.
Published: (2020)

HTA and innovative treatments evaluation: the case of metastatic castration-resistant prostate cancer
by: Bretoni A, et al.
Published: (2019)

Changes of electrocardiograms of animals with epinephrine heart damage in influences of stress and castration
by: R. Druziuk, et al.
Published: (2023)

Calcilytics inhibit the proliferation and migration of human prostate cancer PC-3 cells
by: Aya Yamamura, et al.
Published: (2019)

Piperlongumine, a Novel TrxR1 Inhibitor, Induces Apoptosis in Hepatocellular Carcinoma Cells by ROS-Mediated ER Stress
by: Qianqian Zhang, et al.
Published: (2019)

Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer
by: Channing J Paller, et al.
Published: (2011)

HTA and innovative treatments evaluation: the case of metastatic castration-resistant prostate cancer [Corrigendum]
by: Bretoni A, et al.
Published: (2019)

Abiraterone acetate: oral androgen biosynthesis inhibitor for treatment of castration-resistant prostate cancer
by: Rosenberg JE, et al.
Published: (2012)

Cost-Effectiveness of Genomic Test-Directed Olaparib for Metastatic Castration-Resistant Prostate Cancer
by: Dan Su, et al.
Published: (2021)

Avβ3 Single-Stranded DNA Aptamer Attenuates Vascular Smooth Muscle Cell Proliferation and Migration via Ras-PI3K/MAPK Pathway
by: Hong-Bing Wu, et al.
Published: (2020)

Corrigendum: Piperlongumine, a Novel TrxR1 Inhibitor, Induces Apoptosis in Hepatocellular Carcinoma Cells by ROS-Mediated ER Stress
by: Qianqian Zhang, et al.
Published: (2022)

GRP78-targeted and doxorubicin-loaded nanodroplets combined with ultrasound: a potential novel theranostics for castration-resistant prostate cancer
by: Yading Zhao, et al.
Published: (2022)

Treatment-Emergent Co-Morbidities and Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone or Enzalutamide
by: Yi-Ting Lin, et al.
Published: (2021)

Codelivery of GRP78 siRNA and docetaxel via RGD-PEG-DSPE/DOPA/CaP nanoparticles for the treatment of castration-resistant prostate cancer
by: Zhang X, et al.
Published: (2019)

Analysis of regulating activities of 5'-epiequisetin on proliferation, apoptosis, and migration of prostate cancer cells in vitro and in vivo
by: Xueni Wang, et al.
Published: (2022)

Animal Castration
by: Liautard, Alexandre François Augustin, 1835-1918

Mechanism of baicalein in treatment of castration-resistant prostate cancer based on network pharmacology and cell experiments
by: Baokai Dou, et al.
Published: (2024)

Targeting mTOR Complex 2 in Castration-Resistant Prostate Cancer with Acquired Docetaxel Resistance
by: Huang Y, et al.
Published: (2022)